The Gross Margin of SkinBioTherapeutics PLC (SBTX.L) is 56.51%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-06-30 | 56.51% |
2023-06-30 | 64.51% |
2022-06-30 | 60.65% |